01st week of 2010 patent applcation highlights part 45 |
Patent application number | Title | Published |
20100004411 | POLYMERISATION OF ETHYLENE AND ALPHA-OLEFINS WITH IMINO-QUINOLINOL COMPLEXES - The present invention discloses active oligomerisation or polymerisation catalyst systems based on imino-quinolinol complexes. | 2010-01-07 |
20100004412 | METHOD FOR PREPARING POLYMER BY PRECIPITATION POLYMERIZATION - The present invention provides a method for preparing a polymer by precipitation polymerization, comprising the steps of mixing an antisolvent a), a monomer b), and a catalyst c), and while polymerizing the monomers, simultaneously precipitating a polymer formed by the monomers b) in a solid phase. | 2010-01-07 |
20100004413 | BULK POLYMERIZATION PROCESS FOR PRODUCING POLYDIENES - A process for preparing a polydiene, the process comprising the step of polymerizing conjugated diene monomer with a lanthanide-based catalyst system including the combination or reaction product of: (a) a lanthanide compound selected from the group consisting of lanthanide organophosphates, lanthanide organophosphonates, and lanthanide organophosphinates, (b) an alkylating agent, and (c) a chlorine-containing compound, where said step of polymerizing takes place within a polymerization mixture that includes less than 20% by weight of solvent based on the total weight of the polymerization mixture. | 2010-01-07 |
20100004414 | POLYMERS FUNCTIONALIZED WITH IMIDE COMPOUNDS CONTAINING A PROTECTED AMINO GROUP - A method for preparing a functionalized polymer, the method comprising the steps of preparing a reactive polymer and reacting the reactive polymer with an imide compound containing a protected amino group. | 2010-01-07 |
20100004415 | Fluorine-Containing Elastomer and Composition Thereof - A fluorine-containing elastomer having a copolymer composition, which comprises (a) 50-85 mol. % of vinylidene fluoride, (b) 0-25 mol. % of tetrafluoroethylene, (c) 7-20 mol. % of perfluoro(methyl vinyl ether), (d) 2.5-15 mol. % of CF | 2010-01-07 |
20100004416 | INFILTRANT FOR DENTAL APPLICATION - The invention provides an infiltrant for dental application that comprises crosslinking monomers. In accordance with the invention the infiltrant has a penetration coefficient PC>50 cm/s, and the crosslinking monomers, based on the total mass of monomers, comprise at least 5% by weight of crosslinking monomers having at least three polymerizable groups and not more than 95% by weight of crosslinking monomers having two polymerizable groups. | 2010-01-07 |
20100004417 | METHOD FOR THE ADSORPTIVE PURIFICATION OF ALKYL METHACRYLATES - The invention relates in general terms to a process for preparing to a process for purifying an alkyl methacrylate, comprising the steps of:
| 2010-01-07 |
20100004418 | Method for the Production of Superabsorbers - Superabsorbents are produced by polymerization in the presence of at least one unsaturated polyetherol selected from the group consisting of polyetherols having the following structural formulae (1), (2), (3) and (4): | 2010-01-07 |
20100004419 | HIGH SHEAR ROTARY FIXED BED REACTOR - A reactor comprising at least one contact surface made from, coated with, or impregnated by a catalyst, wherein the contact surface comprises a sintered metal or a ceramic, and wherein the reactor is configured to subject a reactant stream to shear. A system for carrying out a heterogeneously catalyzed reaction, the system comprising a reactor as described above and a pump configured for delivering reactants to the at least one reactor. A method for carrying out a heterogeneously-catalyzed reaction by introducing reactants into a reactor comprising at least one contact surface made from, coated with, or impregnated by a catalyst under conditions which promote production of a desired product, wherein the contact surface comprises a sintered metal or a ceramic, and forming a dispersion of reactants within the reactor, wherein the dispersion comprises droplets or gas bubbles of reactant with an average diameter of less than about 5 μm. | 2010-01-07 |
20100004420 | PROCESS FOR PREPARING A POLYMER POWDER EXTRACT - The present invention relates to a process for preparing a polymer powder extract from a mixture of a polymer powder and a first particulate material. | 2010-01-07 |
20100004421 | RESIN COMPOSITION FOR OPTICAL MATERIAL AND OPTICAL MATERIAL USING THE SAME - According to the present invention, a resin compound for optical material, comprising (a) an episulfide compound represented by a specific structural formula, (b) a xylylenedithiol compound and (c) a xylylenediisocyanate compound can be provided. In a preferable embodiment of the present invention, a resin compound for optical material having superb optical properties, a high density and a high thermal resistance can be provided. Also according to the present invention, an optical material obtained by curing the above-described resin compound can be provided. | 2010-01-07 |
20100004422 | PROCESS FOR THE SYNTHESIS OF ETHERS OF AROMATIC ACIDS - Ethers of aromatic acids are produced from halogenated aromatic acids in a reaction mixture containing a copper (I) or copper (II) source and an amino acid ligand that coordinates to copper. | 2010-01-07 |
20100004423 | PROCESS FOR PREPARATION OF REGIOREGULAR POLY(3-SUBSTITUTED-THIOPHENE) - The invention provides a method of preparing regioregular HT poly(3-substituted-thiophene). The method includes contacting a 3-substituted-thiophene-metal complex with a manganese(II) halide to provide a 3-substituted-thiophene-manganese complex; and contacting the thiophene-manganese complex with a nickel(II) catalyst to provide the regioregular HT poly(3-substituted-thiophene). The substitution at the 3-position can be a variety of different groups. Additionally, unsubstituted and 3,4-disubstituted polythiophenes can also be prepared by the method. Electronic devices can be made using the polymers prepared as described herein. | 2010-01-07 |
20100004424 | Methods for the Formation of Hydrogels Using Thiosulfonate Compositions and Uses Thereof - The present invention provides both crosslinked polymer compositions capable of forming hydrogels upon exposure to an aqueous environment and thiosulfonate hydrogel-forming components. The thiosulfonate hydrogel-forming components of the invention are preferably multi-arm thiosulfonate polymer derivatives that form a crosslinked polymer composition when exposed to a base without requiring the presence of a second cross-linking reagent, redox catalyst, or radiation. Methods for forming hydrogel compositions, as well as methods for using the hydrogels, are also provided. | 2010-01-07 |
20100004425 | SOURCE MATERIAL FOR PREPARING LOW DIELECTRIC CONSTANT MATERIAL - A low dielectric constant material having an excellent water resistance obtained by heat-treating a borazine compound of the formula (1-2): | 2010-01-07 |
20100004426 | Phosphorus-containing compounds and their prepartion process and use - A series of novel phosphorus-containing compounds having the following formula is provided: | 2010-01-07 |
20100004427 | METHOD FOR THE REMOVAL OF ISOBUTENE OLIGOMERS FROM AN ISOBUTENE POLYMER - A process is described for removing isobutene oligomers from an isobutene polymer by stripping the isobutene polymer with vapors of a saturated hydrocarbon having at least 8 carbon atoms and at least partly driving out the isobutene oligomers. Troublesome isobutene oligomers are substantially removed without impairing the reactivity of the isobutene polymer (expressed as the content of the methylidene double bonds). | 2010-01-07 |
20100004428 | Method of Preparing Propionic Acid-Terminated Polymers - The invention provides methods for preparing polymers bearing a terminal propionic acid. The method involves first reacting a water soluble and non-peptidic polymer comprising at least one hydroxyl group with a tertiary alkyl acrylate in the presence of a catalyst to form a propionic acid ester of the polymer, wherein the polymer has a weight average molecular weight of at least about 10,000 Da; and then treating the propionic acid ester of the polymer with a strong acid to form a propionic acid of the polymer. | 2010-01-07 |
20100004429 | AGONIST ANTIBODY TO HUMAN THROMBOPOIETIN RECEPTOR - This invention provides an agonist antibody to a human thrombopoietin receptor (alias: human c-Mpl). More particularly, this invention provides an agonist antibody to a human thrombopoietin receptor, wherein the agonist antibody comprises: antibody constant regions comprising (1) amino acid sequences in a heavy chain constant region and a light chain constant region of a human antibody, (2) an amino acid sequence of a heavy chain constant region with a domain substituted between human antibody subclasses, and an amino acid sequence of a light chain constant region of a human antibody, or (3) amino acid sequences comprising a deletion(s), substitution(s), addition(s), or insertion(s) of one or several amino acid residues in the amino acid sequences of (1) or (2) above; and antibody variable regions capable of binding to and activating a human thrombopoietin receptor; and wherein the agonist antibody has the properties: (a) that the antibody induces colony formation at a concentration of 10,000 ng/ml or lower as determined by the CFU-MK colony formation assay using human umbilical-cord-blood-derived CD34+ cells; and (b) that the antibody has a maximal activity at least 50% higher than that of PEG-rHuMGDF and an 50% effective concentration (EC50) of 100 nM or less in the cell proliferation assay using UT7/TPO cell. Also provided is a pharmaceutical composition for treating thrombocytopenia comprising said antibody. | 2010-01-07 |
20100004430 | PEPTIDE-BASED IMMUNIZATION THERAPY FOR TREATMENT OF ATHEROSCLEROSIS - The present invention relates to antibodies raised against fragments of apolipoprotein B, in particular defined peptides thereof, for immunization or therapeutic treatment of mammals, including humans, against ischemic cardiovascular diseases, using one or more of said antibodies. | 2010-01-07 |
20100004431 | HUMAN EQUIVALENT MONOCLONAL ANTIBODIES ENGINEERED FROM NONHUMAN VARIABLE REGIONS - The present invention is directed to the creation of human equivalent CDRs and antibodies containing them by a method of producing an antibody which specifically binds to an antigen. | 2010-01-07 |
20100004432 | APTAMER AGAINST MIDKINE AND USE THEREOF - Provided is a high-quality aptamer against midkine. | 2010-01-07 |
20100004433 | NOVEL COLLAGEN-LIKE PROTEIN CLAC, PRECURSOR THEREOF AND GENES ENCODING THE SAME - A novel human collagen-like protein CLAC occurring in brain amyloid and its precursor CLAC-P; genes encoding the same; cDNA of mouse CLAC-P and its deduced amino acid sequence; antibodies specific to these proteins; and methods of diagnosing treating and preventing Alzheimer's disease by using the same. | 2010-01-07 |
20100004434 | METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA - The invention is directed to compositions and methods for selectively reducing the expression of a gene product from a desired target gene in a cell, as well as for treating diseases caused by the expression of the gene. More particularly, the invention is directed to compositions that contain double stranded RNA (“dsRNA”), and methods for preparing them, that are capable of reducing the expression of target genes in eukaryotic cells. The dsRNA has a first oligonucleotide sequence that is between 25 and about 30 nucleotides in length and a second oligonucleotide sequence that anneals to the first sequence under biological conditions. In addition, a region of one of the sequences of the dsRNA having a sequence length of at least 19 nucleotides is sufficiently complementary to a nucleotide sequence of the RNA produced from the target gene to trigger the destruction of the target RNA by the RNAi machinery. | 2010-01-07 |
20100004435 | METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA - The invention provides compositions and methods for selectively reducing the expression of a gene product from a desired target gene, as well as treating diseases caused by expression of the gene. The method involves introducing into the environment of a cell an amount of a double-stranded RNA (dsRNA) such that a sufficient portion of the dsRNA can enter the cytoplasm of the cell to cause a reduction in the expression of the target gene. The dsRNA has a first oligonucleotide sequence that is between 26 and about 30 nucleotides in length and a second oligonucleotide sequence that anneals to the first sequence under biological conditions. In addition, a region of one of the sequences of the dsRNA having a sequence length of from about 19 to about 23 nucleotides is complementary to a nucleotide sequence of the RNA produced from the target gene. | 2010-01-07 |
20100004436 | METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA - The invention provides compositions and methods for selectively reducing the expression of a gene product from a desired target gene, as well as treating diseases caused by expression of the gene. The method involves introducing into the environment of a cell an amount of a double-stranded RNA (dsRNA) such that a sufficient portion of the dsRNA can enter the cytoplasm of the cell to cause a reduction in the expression of the target gene. The dsRNA has a first oligonucleotide sequence that is between 26 and about 30 nucleotides in length and a second oligonucleotide sequence that anneals to the first sequence under biological conditions. In addition, a region of one of the sequences of the dsRNA having a sequence length of from about 19 to about 23 nucleotides is complementary to a nucleotide sequence of the RNA produced from the target gene. | 2010-01-07 |
20100004437 | Chemical Transformation of Lignocellulosic Biomass into Fuels and Chemicals - A method for converting a carbohydrate to a furan in a polar aprotic solvent in the presence of a chloride, bromide, or iodide salt or a mixture thereof and optionally in the presence of an acid catalyst, a metal halide catalyst and/or an ionic liquid (up to 40 wt %). The method can be employed in particular to produce furfural or 5-hydroxymethylfurfural. | 2010-01-07 |
20100004438 | DIARYLETHER DERIVATIVES AS ANTITUMOR AGENTS - An object of the present invention is to provide a medicinal drug much improved in anti tumor activity and excellent in safety. According to the present invention, there is provided a medicinal drug containing a compound represented by the following general formula (1) or a salt thereof as an active ingredient: [Formula 1] wherein X | 2010-01-07 |
20100004439 | Heterocyclic Compound - A compound represented by the following Formula (1): | 2010-01-07 |
20100004440 | Novel acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same - The present invention relates to an acyclic nucleoside phosphonate derivative which is useful as an antiviral agent (particularly, against hepatitis B virus), pharmaceutically acceptable salts, stereoisomers, and a process for the preparation thereof. | 2010-01-07 |
20100004441 | N-(5-Membered Aromatic Ring)-Amido Anti-Viral Compounds - Disclosed are compounds having Formula (I) and the compositions and methods thereof for treating or preventing a viral infection mediated at least in part by a virus in the Flaviviridae family of viruses, wherein A, R | 2010-01-07 |
20100004442 | Preparation of amorolfine - Amorolfine base, which is a compound of formula (I): | 2010-01-07 |
20100004443 | LINEAR PYRIDAZINE AND PYRROLE COMPOUNDS, METHOD FOR OBTAINING THEM AND APPLICATIONS - The present invention relates to linear pyridazine compounds, and more particularly to those of these compounds which are oligopyridazine compounds, to processes for obtaining them, to their uses, and also to their reduction to pyrroles and to the uses of the pyrrole, pyridazinylpyrrole and oligopyrrole compounds obtained. The invention relates in particular to the uses as medicaments, in particular for treating pathologies such as cancer, bacterial infections or parasitic infections, and also the applications in the materials, environmental, electronics and optics field. | 2010-01-07 |
20100004444 | Novel Triazolo pyrimidine compounds - The present invention relates to a pyrimidine compound (I) useful as a pharmaceutical intermediate, to a process for preparing said pyrimidine compound, to intermediates used in said process, and to the use of said pyrimidine compound in the preparation of pharmaceuticals. | 2010-01-07 |
20100004445 | METHODS FOR THE SYNTHESIS OF UNSYMMETRICAL CYCLOALKYL SUBSTITUTED XANTHINES - The present invention provides compounds and pharmaceutical compositions that are selective antagonists of A | 2010-01-07 |
20100004446 | Process for the Preparation of Abacavir - Process for removal of the amino protective group of a N-acylated [(1S,4R)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-cyclopent-2-enyl]methanol of formula (II) where R═H or a (C | 2010-01-07 |
20100004447 | PROCESS FOR PREPARATION OF 9-HYDROXY-3-(2-CHLOROETHYL)-2-METHYL-4H-PYRIDO[1,2-A]PYRIMIDIN-4-ONE HYDROCHLORIDE - Described herein is an improved, commercially viable and industrially advantageous process for the preparation of paliperidone intermediate 9-hydroxy-3-(2-chloroethyl)-2-methyl-4h-pyrido[1,2-a]pyrimidin-4-one and its hydrochloride salt. The process provides the paliperidone intermediate in higher yield and reduced reaction time compared to the previously disclosed processes, thereby providing for production of paliperidone and its pharmaceutically acceptable acid addition salts in high purity and in high yield. | 2010-01-07 |
20100004448 | METHODS OF PREPARING QUINAZOLINONE DERIVATIVES - The present disclosure relates to methods for preparing compounds, which are useful for regulating the expression of apolipoprotein A-I (ApoA-I), and in the treatment and prevention of cardiovascular disease and related disease states, including cholesterol- or lipid-related disorders, such as, for example, atherosclerosis. | 2010-01-07 |
20100004449 | CRYSTALLINE FORMS OF ERLOTINIB BASE AND ERLOTINIB HCL - The preparation of crystalline Erlotinib base form G2 is described. This crystalline form can be converted to an Erlotinib salt, such as Erlotinib HCl, which can be used in the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC). | 2010-01-07 |
20100004450 | Process for the preparation of substituted pyrimidine derivatives - The present invention is directed to processes for the preparation of substituted pyrimidine derivatives, useful as intermediates in the synthesis of histamine H | 2010-01-07 |
20100004451 | VARENICLINE TOSYLATE, AN INTERMEDIATE IN THE PREPARATION PROCESS OF VARENICLINE L-TARTRATE - Crystalline forms of Varenicline Tosylate, processes for preparing those crystalline forms of Varenicline Tosylate, and processes for obtaining high purity Varenicline base using Varenicline Tosylate are provided. | 2010-01-07 |
20100004453 | PROCESS FOR PREPARATION OF METHYL-(+)-(S)-ALPHA-(2-CHLOROPHENYL)-6, 7-DIHYDROTHIENO[3,2-C]PYRIDINE-5 (4H) -ACETIC ACID METHYL ESTER OR SALTS THEREOF HAVING HIGHER CHIRAL PURITY AND PRODUCTS THEREOF - A process for preparation of Methyl-(+)-(S)-alpha-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetic acid methyl ester or salts thereof [clopidogrel or salts thereof of Formula (I)] having higher chiral purity and products thereof is provided. A process for purification of the compound prepared is also provided to enhance its efficacy by enhancing its optical rotation and chiral purity. In Formula (I), R is selected from a group comprising alkyl, alkoxy, hydroxy, amine etc., and R | 2010-01-07 |
20100004454 | QUINOLINIUM ION DERIVATIVES, PROCESS FOR THE PRODUCTION OF THE DERIVATIVES, PRODUCTS MADE BY USING THE SAME, AND REDUCTION AND OXIDATION METHODS WITH THE DERIVATIVES - An electron donor-acceptor dyad is provided that can provide a charge-separated state with longevity and not only high oxidizing power but also high reducing power. A compound of the present invention is a quinolinium ion derivative represented by the following formula (I), a stereoisomer or tautomer thereof, or a salt thereof: | 2010-01-07 |
20100004455 | Method for producing piperidin-4-one derivative - Provided is a method for producing a piperidin-4-one derivative useful as an intermediate for agricultural chemicals or pharmaceutical products. A piperidin-4-one derivative represented by formula (III-a) or formula (III-b) is produced by reacting a cyclic bis(aminol)ether compound represented by formula (I) and an acetone derivative represented by formula (II) in the presence of at least one substance selected from the group consisting of protonic acids, Lewis acids, acid halides and dialkyl sulfuric acids. | 2010-01-07 |
20100004456 | Oxepin derivative - The present invention provides a compound, an oxepin derivative having excellent histamine receptor antagonistic action, which is useful as an antihistamine. The oxepin derivative of the present invention has a potent histamine receptor antagonistic action. Further, the compound of the present invention shows low intracerebral migration even when a mouse that is orally administered with the compound is subjected to an intracerebral receptor binding test, so that the compound has preferred properties of alleviating side effects in the central nervous system, such as drowsiness. The oxepin derivative of the present invention is very useful as a novel antihistamine having smaller side effects in the central nervous system, such as drowsiness. | 2010-01-07 |
20100004457 | PROCESS FOR THE PREPARATION OF 2-TRIFLUOROMETHYL-5-(1-SUBSTITUTED)ALKYLPYRIDINES - 2-Trifluoromethyl-5-(1-substituted)alkylpyridines are produced efficiently and in high yield from an alkyl vinyl ether and trifluoroacetyl chloride by cyclization. | 2010-01-07 |
20100004458 | PROCESS FOR PRODUCING CRYSTAL - The present invention relates to a production method of a crystal of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]benzimidazole.n′H | 2010-01-07 |
20100004459 | 2-PHENYLNICOTINIC ACID DERIVATIVE - The present invention is to provide the compounds useful as a treating or preventing agent for gout and hyperuricemia which are 2-phenylnicotinic acid derivatives having a uric acid lowering action due to an excellent xanthine oxidase inhibitory action. Since the 2-phenylnicotinic acid derivatives of the present invention exhibit a uric acid lowering action due to an excellent xanthine oxidase inhibitory action and also hypolipemic action, their utility is very high as a treating or preventive agent for gout and hyperuricemia which are often accompanied by hyperlipemia as a complication. | 2010-01-07 |
20100004460 | METHOD FOR PRODUCING 2-NITROIMIDAZOLE DERIVATIVE - It is an object to provide a method for producing a 2-nitroimidazole derivative having an acyclic sugar chain in a side chain, which is suitable for production of a derivative having a radioisotope. | 2010-01-07 |
20100004461 | COMPOUNDS CONTAINING ORGANOFLUOROCHLOROPHOSPHATE ANIONS - The present invention relates to compounds containing organofluorochlorophosphate anions, the preparation thereof and the use thereof, in particular as ionic liquids. | 2010-01-07 |
20100004462 | PROCESS FOR PREPARING (METH)ACRYLIC ESTERS OF N-HYDROXYALKYLATED IMIDAZOLES - A process for preparing (meth)acrylic esters (F) of N-hydroxyalkylated imidazoles, wherein N-hydroxyalkylated imidazoles (I), | 2010-01-07 |
20100004463 | PROCESS FOR SYNTHESIZING CARBAPENEM USING RANEY NICKEL - Convenient method for obtaining carbapenem by hydrogenation with Raney Nickel, as an alternative to the known catalytic hydrogenation conducted under hydrogen overpressure in the presence of Palladium, starting from corresponding protected intermediates such as p-nitrobenzylesters and with optional suitable protections of any primary and secondary amino functions structurally present. | 2010-01-07 |
20100004464 | Method for producing succinimide compound - There is provided a method for producing a succinimide compound. The method for producing a succinimide compound of formula (3) comprises reacting an aminomalonic ester compound of formula (1) with a compound of formula (2) in a solvent in the presence of a base, wherein an alcohol is used as the solvent and an alkali metal alkoxide is used as the base. | 2010-01-07 |
20100004465 | C-PHENYL 1-THIOGLUCITOL COMPOUND - C-phenyl 1-thioglucitol compounds of the following formula (I) or pharmaceutically acceptable salts thereof or hydrates thereof: | 2010-01-07 |
20100004466 | Benzothiophen-2-carbonylguanidine derivatives, preparation thereof, and pharmaceutical composition containing the same - The present invention is related to benzothiophen-2-carbonylguanidine derivatives, a preparation method thereof, and pharmaceutical compositions containing the same. The derivatives have potent inhibitory effect on the sodium/hydrogen exchanger NHE-I, improve the functional recovery of ischemia/reperfusion-induced heart injury in isolated ischemic heart models, and significantly reduce the myocardiac infarct size in in vivo ischemic animal models, thereby showing excellent cardioprotective effects. Also, the derivatives are protective of both neuronal cells and the brain as proven by their protective effects on neuronal cells from necrosis and apoptosis and by their ability to significantly reduce cerebral infarct sizes in in vivo ischemic brain models. The derivatives can be effectively used for the prevention and treatment of ischemic heart diseases such as myocardiac infarction, arrhythmia, angina pectoris and the like, and cerebrovascular diseases such as cerebral stroke and be used as cardioprotective agents to the patients undergoing reperfusion therapy including chemicals such as thrombolytic agents, or surgery such as coronary artery bypass and percutaneous transluminal coronary angioplasty. | 2010-01-07 |
20100004467 | COMPOUNDS COMPRISING A LINEAR SERIES OF FIVE FUSED CARBON RINGS, AND PREPARATION THEREOF - The present application discloses methods for the production of organic compounds comprising a linear series of five fused carbon rings. Such compounds are useful in the production of electronic components, devices and materials. For example the methods disclosed permit the production of 2,9- and 2,10-disubstituted pentacene compounds and 2,6,9,13- and 2,6,10,13-tetrasubstituted compounds that present particularly advantageous properties for the manufacture of semiconductor materials, and may be used in devices such as for example thin film transistors and solar cells. These features are enhanced by π-π parallel stacking in the solid state. Also disclosed are compounds that are excellent candidates for use in the manufacture of semiconductor materials, and other components of electronic systems, by virtue of their solubility, crystal packing geometries, and electronic properties. | 2010-01-07 |
20100004468 | CARBON NANOTUBE ADDUCTS AND METHODS OF MAKING THE SAME - The invention provides an adduct comprising a carbon nanotube and a transitional metal coordination complex, wherein the metal of the complex is attached by a covalent linkage to at least one oxygen moiety on the nanotube. | 2010-01-07 |
20100004469 | ANTIMICROBIAL AGENTS AND MICROBICIDAL AGENTS - An antimicrobial agent comprising, as an active component, compounds represented by the following formula | 2010-01-07 |
20100004470 | 4-((PHENOXYALKYL)THIO)-PHENOXYACETIC ACIDS AND ANALOGS - The invention features 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs, compositions containing them, and methods of using them as PPAR delta modulators to treat or inhibit the progression of, for example, dyslipidemia. | 2010-01-07 |
20100004471 | PURIFICATION OF P-DIOXANONE - The present disclosure provides methods for purifying p-dioxanone. In embodiments, crude p-dioxanone may be contacted with at least one isocyanate-functionalized scavenger. The at least one isocyanate-functionalized scavenger may react with hydroxyl compounds present with the crude p-dioxanone to form reaction products, in embodiments polyurethanes and/or polyureas, which may then be removed. The p-dioxanone thus obtained is of greater purity than the starting crude p-dioxanone. | 2010-01-07 |
20100004472 | BIOSURFACTANT-CONTAINING SKIN CARE COSMETIC AND SKIN ROUGHNESS-IMPROVING AGENT - The present invention relates to a cosmetic for skin roughness improvement/skin care containing a biosurfactant, particularly MEL-A, MEL-B or MEL-C. | 2010-01-07 |
20100004473 | METHOD FOR PRODUCING COENZYME Q10 PARTICLE - The present invention aims to provide a production method capable of industrially and producing coenzyme Q | 2010-01-07 |
20100004474 | Methods Of Processing Ethanol Byproducts And Related Subsystems - In one aspect of the invention, a method recovers oil from a concentrated byproduct, such as evaporated thin stillage formed during a dry milling process used for producing ethanol. The method includes forming a concentrate from the byproduct and recovering oil from the concentrate. The step of forming the concentrate may comprise evaporating the byproduct. Further, the step of separating the oil from the concentrate may comprise using a centrifuge and, in particular, a disk stack centrifuge. Other aspects of the invention include related methods and subsystems for recovering oil from thin stillage. | 2010-01-07 |
20100004475 | PROCESS FOR PREPARING ISOCYANATOORGANOSILANES - The invention provides a process for preparing silanes which possess an isocyanate function, in which the silanes, after their chemical preparation, are purified and, after the purification, are handled exclusively in an atmosphere with a relative air humidity below 10%. | 2010-01-07 |
20100004476 | Hydrosilylation process for gaseous unsaturated hydrocarbons - Organosilicon compounds are prepared by the addition reaction of a gaseous unsaturated hydrocarbon with a silane or siloxane containing at least one silicon-bonded hydrogen atom in the presence of a hydrosilylation catalyst in a liquid reaction medium. In this process the unsaturated hydrocarbon and optionally the silane or siloxane is dispersed into the liquid reaction medium by a jet eductor (also known as a venturi pump) device and the resultant gas-in-liquid dispersion is introduced into a bubble reactor. | 2010-01-07 |
20100004477 | NOVEL CRYSTAL OF 5-AMINOLEVULINIC ACID PHOSPHATE AND PROCESS FOR PRODUCING THE SAME - To provide a novel crystal of 5-aminolevulinic acid phosphate having a high thermal stability, a high melting point, and an excellent moisture absorption resistance as well as a process for producing the same. | 2010-01-07 |
20100004478 | FLUORINATED ALCOHOLS - A compound comprising Formula 5 | 2010-01-07 |
20100004479 | PROCESSES FOR PRODUCING CARBONIC ESTER AND PRODUCING POLYCARBONATE - A process for producing a carbonic ester, characterized in that an aromatic monohydroxy compound or an aliphatic monohydroxy compound is subjected to oxidative carbonylation with carbon monoxide and oxygen in the presence of a palladium catalyst using a compound having a carbonate bond as a reaction solvent. A process for producing a polycarbonate, characterized in that an aromatic dihydroxy compound or an aliphatic dihydroxy compound is subjected to oxidative carbonylation with carbon monoxide and oxygen in the presence of a palladium catalyst using a compound having a carbonate bond as a reaction solvent is also described. The carbonic ester can be produced with a higher yield and at a higher reaction rate and, also, a polycarbonate having a higher molecular weight as compared with the conventional method can be produced with a higher yield and at a higher reaction rate. | 2010-01-07 |
20100004480 | METHODS AND COMPOSITIONS FOR INHIBITING BIOFILMS - The present invention discloses compounds, compositions, and methods of using such compounds and compositions to inhibit, reduce, prevent, and remove biofilms. The invention further relates to methods of inhibiting biofilms on various substrates, such as medical devices. | 2010-01-07 |
20100004481 | L-THREONINE DERIVATIVES OF HIGH THERAPEUTIC INDEX - The present invention is directed to a derivative comprised of an L-Threonine bonded to a medicament or drug having a hydroxy, amino, carboxy or acylating derivative thereon. The derivative has the same utility as the drug from which it is made, but it has enhanced therapeutic properties. In fact, the derivatives of the present invention enhance at least one or more therapeutic qualities, as defined herein. The present invention is also directed to pharmaceutical compositions containing same. | 2010-01-07 |
20100004482 | FLUORINATED ESTERS - A compound comprising Formula 2A, 2B, or 2C | 2010-01-07 |
20100004483 | Novel Process For The Synthesis Of (E)-Stilbene Derivatives Which Makes It Possible To Obtain Resveratrol And Piceatannol - A subject-matter of the present invention is a novel process for the synthesis of (E)-stilbene derivatives targeted at obtaining in particular resveratrol and piceatannol. | 2010-01-07 |
20100004484 | METHOD OF REPLACING DISPERSION MEDIUM - A method of replacing a first dispersion medium in a starting slurry composed of the first dispersion medium and isophthalic acid crystals with a second dispersion medium. The starting slurry is tangentially fed to a vertically extending cylindrical portion of a cyclone-shaped nozzle disposed at an upper portion of a replacement tank of a dispersion medium replacement apparatus, from a tangential direction of the cylindrical portion. The fed starting slurry moves circularly along an inner wall of the cylindrical portion. The slurry circularly moving is then discharged from an opening which is disposed at a vertically lower end of the cylindrical portion and dispersed in a second dispersion medium which is fed from a lower portion of the replacement tank. The replaced slurry composed of isophthalic acid crystals and the second dispersion medium is mainly discharged from the lower portion of the replacement tank, and the first dispersion medium is mainly withdrawn from the upper portion of the replacement tank. | 2010-01-07 |
20100004485 | GABAPENTIN ENACARBIL SALTS AND PROCESSES FOR THEIR PREPARATION - The preparation and use of calcium, barium, magnesium and copper salts of gabapentin enacarbil are described. | 2010-01-07 |
20100004486 | PROCESS FOR PRODUCING METHIONINE - The present invention provides a process for producing methionine which is advantageous from the viewpoints of cost and wastewater disposal, and which comprises the following steps (1) to (5): | 2010-01-07 |
20100004487 | Clathrate hydrate containing quaternary ammonium salt as guest compound - An aqueous solution containing a quaternary ammonium salt as a guest compound of a clathrate hydrate, having a property of producing the clathrate hydrate when cooled, and further containing a phosphate of an alkali metal added thereto. A clathrate hydrate produced by cooling an aqueous solution containing a quaternary ammonium salt and a phosphate of an alkali metal, wherein the quaternary ammonium salt is the guest compound. | 2010-01-07 |
20100004488 | PROCESS FOR PRODUCTION OF 2,6-DIMETHYL-1-NAPHTHALDEHYDE - 2,6-Dimethyl-1-naphthaldehyde having a ratio of the amount of 3,7-dimethyl-1-naphthaldehyde to the total amount of 2,6-dimethyl-1-naphthaldehyde and 3,7-dimethyl-1-naphthaldehyde of 30 mol % or less is particularly useful as optical functional materials, etc. The present invention provides a process for producing such 2,6-dimethyl-1-naphthaldehyde in an industrially advantageous manner. Specifically, in the process for producing 2,6-dimethyl-1-naphthaldehyde through formylation of 2,6-dimethylnaphthalene with carbon monoxide, formylation is performed in the presence of hydrogen fluoride in an amount of 5 to 100 times by mole and boron trifluoride in an amount of 0.5 to 3.5 times by mole, with respect to 2,6-dimethylnaphthalene, and at a reaction temperature of 35 to 70° C. | 2010-01-07 |
20100004489 | PROCESS FOR PRODUCING 2,2,3-TRIMETHYLCYCLOPENT-3-ENECARBALDEHYDE (CAMPHOLYTIC ALDEHYDE) - A method for the production of campholytic aldehyde starting from campholenic aldehyde in the presence of a copper catalyst and a solvent. | 2010-01-07 |
20100004490 | PROCESS FOR THE PREPARATION OF CHLOROMETHYL 2,2,2-TRIFLUORO-1-(TRIFLUOROMETHYL) ETHYL ETHER - The present invention refers to a process for the preparation of chloromethyl 2,2,2-trifluoro-1-(trifluoromethyl) ethyl ether (sevochlorane), which consists of reacting hexafluoroisopropanol with: a formaldehyde equivalent selected between paraformaldehyde or 1,3,5-trioxane, a chlorinating agent selected from the group consisting of oxalyl chloride, phosphorus trichloride, phosphorus pentachloride, phosphorus oxychloride, sulfuryl chloride and thionyl chloride, and a strong acid selected from the group consisting of concentrated or fuming sulfuric acid. Said process provides sevochlorane in high purity and yield, which can be converted to sevoflurane by known means. | 2010-01-07 |
20100004491 | Method Of Fuse Oil Decanting In An Ethanol Plant - An apparatus including an ethanol stream, wherein said ethanol stream contains greater than 5% of water; a dehydration means, wherein the water content of said ethanol stream is reduced to less than 5%; a desiccation means, wherein the water content of said ethanol stream is reduced to less than about 1%; a 200 proof receiver, wherein said 200 proof receiver comprises a sample port or a sensor to allow the percentage of water in the ethanol to be determined, and wherein said 200 proof receiver comprises an outlet; a heat exchanger to heat said ethanol stream with less than 1% water, and a mixing manifold downstream of said heat exchanger, wherein said heated ethanol stream with less than 1% water is combined with fusal oils from a fusal oil decanter is provided. | 2010-01-07 |
20100004492 | Catalytic Production Processes for Making Tetrafluoropropenes and Pentafluoropropenes - A process is disclosed for making CF | 2010-01-07 |
20100004493 | Integrated Process - The invention relates to the integration of plural processes around a single device. The plural processes are characterized by having at least two separate and distinct feedstreams, two separate and distinct products, or a combination thereof. | 2010-01-07 |
20100004494 | CONVERSION OF METHANE INTO C3.about.C13 HYDROCARBONS - A process for preparing C | 2010-01-07 |
20100004495 | PROCESS FOR PRODUCING CARBON DIOXIDE AND METHANE BY CATALYTIC GAS REACTION - It is disclosed a process for producing methane and oxygen through the combustion of organic material, in said combustion there being formed carbon dioxide and carbon monoxide. The reaction is performed in a catalytic gas reactor in the presence of water. | 2010-01-07 |
20100004496 | Integrated Processes for Making Detergent Range Alkylbenzenes from C5-C6-Containing Feeds - Integrated processes for making detergent range alkylbenzenes from C | 2010-01-07 |
20100004497 | Integrated Processes for Making Detergent Range Alkylbenzenes from C5-C6-Containing Feeds - Integrated processes for making detergent range alkylbenzenes from C | 2010-01-07 |
20100004498 | Reducing the profile of neutron-activated 60Co and removing in layers at the primary system of a permanently shut down nuclear power plant in order to accelerate its dismantling - The Decommissioning Phase SAFSTOR for Nuclear Power Plants, lasting for 50 to 60 years before dismantling begins, is to allow for natural decay of | 2010-01-07 |
20100004499 | Methods And Devices For Minimally-Invasive Extraocular Delivery of Radiation To The Posterior Portion Of The Eye - Methods and devices for minimally-invasive delivery of radiation to the posterior portion of the eye including a cannula comprising a distal portion connected to a proximal portion and a means for advancing a radionuclide brachytherapy source (RBS) toward the tip of the distal portion; a method of introducing radiation to the human eye comprising inserting a cannula between the Tenon's capsule and the sclera of the human eye and emitting the radiation from the cannula on an outer surface of said sclera. | 2010-01-07 |
20100004500 | SYSTEMS AND METHODS FOR VARYING ELECTROMAGNETIC AND ADJUNCTIVE NEURAL THERAPIES - Systems and methods for varying electromagnetic and adjunctive neural therapies are disclosed. A method in accordance with one embodiment includes applying electromagnetic signals to a target neural population of a patient over a first period of time in accordance with a first mode (e.g., including signal delivery to the central nervous system or peripheral nervous system, via implanted or non-implanted devices). The method can further include applying electromagnetic stimulation to the patient over a second period of time in accordance with a second mode different than the first mode. Varying the mode between the first period of time and second period of time can increase the efficacy and/or longevity of the stimulation. Systems in accordance with other embodiments can support multiple signal delivery devices. | 2010-01-07 |
20100004501 | VENTRICULAR ASSIST DEVICE AND RELATED METHODS - A method and system are provided for percutaneously gaining access to oxygenated blood with an anastomosis device and pumping such oxygenated blood to other arterial regions of the vascular system via an LVAD system. In one embodiment, a system may include an anastomosis device extending through an opening of the atrial septum. A filament may be coupled to the anastomosis device. A snare device may access the right atrium through the superior vena cava, grasp the filament, and withdraw the filament through the superior vena cava. The filament may then be used as a guide to direct a catheter, a conduit or some other structure into the right atrium of the heart via the superior vena cava. A flow path may be defined between the anastomosis device and an arterial location, such as in the aorta, such that at least some oxygenated blood may by-pass the left ventricle and be discharged into the aorta. | 2010-01-07 |
20100004502 | Grommet Structure in Incubator - In this invention, a grommet structure in an incubator includes a grommet attaching portion provided to the enclosure of the incubator and a grommet member attached to the grommet attaching portion. The grommet member includes a longitudinal member holding incision to hold a longitudinal member such as an oxygen supply tube that extends through it. The longitudinal member holding incision forms at least one substantially S-shaped shape (in other words, a substantially sine-curved shape) and/or a substantially waving shape. This invention can provide the grommet structure in the incubator, in which the longitudinal member such as an oxygen supply tube held by the longitudinal incision of the grommet member and extending through the incision is less likely to move accidentally in the longitudinal direction of the incision or in the longitudinal direction of the longitudinal member. Also, a gap through which the inside and outside of the enclosure communicate with each other can be small even when the longitudinal member extends through the incision. | 2010-01-07 |
20100004503 | APPARATUS AND A METHOD OF ENHANCING A PERSON'S SPORTING ABILITY - This invention relates a recording that is adapted to enhance a person's ability to perform one or more surfing related tasks. The recording includes a hypnotic stage that includes words and/or phrases and/or sentences and/or sounds that are adapted to induce a state of hypnosis in the person when the while the person is listening to the recording. The hypnotic stage of the recording is followed by one or more behavioural messages or instructions that are directed at surfing related actions the person must execute, namely to “paddle hard”, “charge in” and “stay focused”, if the surfing related task or tasks are to be performed or performed with a predetermined level of expertise, and wherein each of said behavioural messages or instructions is subsequently reinforced at least once during the recording by at least one affirmation concerning the person's ability to execute said messages or instructions. | 2010-01-07 |
20100004504 | EPICARDIAL CLIP - An epicardial clip for reshaping the annulus of the mitral valve of a heart. The epicardial clip includes a curved member having an anterior segment configured to be positioned in the transverse sinus of the heart, a posterior segment configured to be positioned on the posterior side of the heart, such as on or inferior to the atrioventricular groove, and a lateral segment extending between the anterior segment and the posterior segment. The lateral segment includes a curve such that the first end of the member is positioned at or above the plane of the mitral valve and the second end of the member is positioned at or below the plane of the mitral valve. | 2010-01-07 |
20100004505 | ENDOSCOPE APPARATUS - When an operation instruction is input by a first (second) control output instruction input device, locus calculation means calculates a locus of movement of a first (second) therapeutic device on the basis of any one of joint sections, which is instructed to operate. On the basis of a calculation result by the locus calculation means, therapeutic device operation control means controls an operation of the first (second) therapeutic device by a first (second) active mechanism. Thereby, there is provided an endoscope apparatus which can improve the operational efficiency and positional precision of the therapeutic device. | 2010-01-07 |
20100004506 | TISSUE VISUALIZATION AND MANIPULATION SYSTEMS - Tissue visualization and manipulation systems are described herein. Such a system may include a deployment catheter and an attached imaging hood deployable into an expanded configuration. In use, the imaging hood is placed against or adjacent to a region of tissue to be imaged in a body lumen that is normally filled with an opaque bodily fluid such as blood. A translucent or transparent fluid, such as saline, can be pumped into the imaging hood until the fluid displaces any blood, thereby leaving a clear region of tissue to be imaged via an imaging element in the deployment catheter. Additionally, any number of therapeutic tools can also be passed through the deployment catheter and into the imaging hood for treating the tissue region of interest. | 2010-01-07 |
20100004507 | ENDOSCOPE DEVICE AND ENDOSCOPIC IMAGE DISTORTION CORRECTION METHOD - The present invention is an endoscope device in which a portion of the optical system can be changed using an optical adaptor, provided with: an image pickup member for capturing an image that is input from an optical system that incorporates a reference scope or user scope, and an optical adaptor; a first recording medium that records a first information that includes at least distortion parameters of the reference scope which indicate the optical properties of the reference scope; a second recording medium that records a second information that includes at least distortion parameters of the user scope which indicate the optical properties of the user scope; and a distortion correcting member that corrects distortion in the image captured by the image pickup member when the user scope and the optical adaptor are combined, based on the first information which is read out from the first recording medium and the second information which is read out from the second recording medium. | 2010-01-07 |
20100004508 | MULTIJOINTED BENDING MECHANISM AND MULTIJOINTED MEDICAL EQUIPMENT HAVING MULTIJOINTED BENDING MECHANISM - A multijointed bending mechanism having a first bending piece, a second bending piece connected to the first bending piece so as to be rotatable around a first rotation shaft, a third bending piece connected to the second bending piece so as to be rotatable around a second rotation shaft, at least two first wires connected to the first bending piece to rotate the first bending piece and at least two second wires connected to the second bending piece to rotate the second bending piece. The first wires are disposed inwards of the second wires with respect to a vertical direction of the first and second rotation shafts. | 2010-01-07 |
20100004509 | MULTIJOINTED BENDING MECHANISM AND MULTIJOINTED MEDICAL EQUIPMENT HAVING MULTIJOINTED BENDING MECHANISM - A multijointed bending mechanism having a first bending piece, a second bending piece connected to the first bending piece so as to be rotatable around a first rotation shaft, a third bending piece connected to the second bending piece so as to be rotatable around a second rotation shaft, at least two first wires connected to the first bending piece to rotate the first bending piece and at least two second wires connected to the second bending piece to rotate the second bending piece. The first wires and the second wires are disposed concentrically with respect to a vertical direction of the first rotation shaft and the second rotation shaft. | 2010-01-07 |
20100004510 | ENDOSCOPE WASHING AND DISINFECTING APPARATUS AND LIQUID SUPPLY MOUTHPIECE - An endoscope washing and disinfecting apparatus of the present invention includes a first channel member in which a projection portion abuts on a fitting surface in a channel mouthpiece, and a first channel internally provided communicates with a suction channel inside the channel mouthpiece, a second channel member which is fitted and fixed to an outer periphery of the first channel member, and is internally provided with a second channel which communicates with the first channel, a pressing member which is provided in the second channel, and presses the first channel member to the channel mouthpiece side in the second channel, and a liquid introduction port which is formed in the second channel member and introduces a liquid to the second channel. | 2010-01-07 |
20100004511 | VARIABLE SPECTROSCOPY ELEMENT, SPECTROSCOPY APPARATUS, AND ENDOSCOPE SYSTEM - Desired spectral characteristics are achieved while achieving reduced size and decreased noise, and detecting the distance between optical substrates with superior precision. Provided is a variable spectroscopy element ( | 2010-01-07 |